Search company, investor...

Coulter Pharmaceutical

Stage

Acq - P2P | Acquired

Total Raised

$43.1M

Valuation

$0000 

About Coulter Pharmaceutical

Coulter Pharmacuetical develops therapeutic antibodies and targeted oncologics to treat cancer.

Headquarters Location

600 Gateway Boulevard

South San Francisco, California, 94080,

United States

650-553-2000

Missing: Coulter Pharmaceutical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Coulter Pharmaceutical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Coulter Pharmaceutical Frequently Asked Questions (FAQ)

  • Where is Coulter Pharmaceutical's headquarters?

    Coulter Pharmaceutical's headquarters is located at 600 Gateway Boulevard, South San Francisco.

  • What is Coulter Pharmaceutical's latest funding round?

    Coulter Pharmaceutical's latest funding round is Acq - P2P.

  • How much did Coulter Pharmaceutical raise?

    Coulter Pharmaceutical raised a total of $43.1M.

  • Who are the investors of Coulter Pharmaceutical?

    Investors of Coulter Pharmaceutical include Corixa, Narragansett Asset Management, Historic New England, Wheaton College Endowment, Navistar and 16 more.

  • Who are Coulter Pharmaceutical's competitors?

    Competitors of Coulter Pharmaceutical include Brain Tunnelgenix Technologies, Mercator MedSystems, Clarient, Beta-O2 Technologies, World Heart and 11 more.

Compare Coulter Pharmaceutical to Competitors

L
Ligon Discovery

Ligon Discovery is a drug discovery company built around the firm's primary technology platform, Small-Molecule Microarrays (SMMs).

B
Brain Tunnelgenix Technologies

Brain Tunnelgenix Technologies develops medical devices and equipment. It provides non-invasive and continuous wearable technology that tracks human brain temperature through the brain's thermal tunnel. The company was founded in 2006 and is based in Aventura, Florida.

M
Mercator MedSystems

Mercator MedSystems has developed a broad-based therapeutic platform that allows clinicians to accurately and efficiently deliver drugs and biologics such as stem cells to tissues deep in the body, treating the root cause of significant medical conditions. The company utilizes its family of Micro-Infusion Catheters for targeted treatments via the vascular system, including peripheral artery disease (PAD) and resistant hypertension (HTN); and via the bronchial tree, including malignant airway obstruction secondary to lung cancer. The company's 510(k)-cleared and CE-Marked Cricket and Bullfrog Micro-Infusion Catheters are vascular-access systems that are able to inject drugs, genes, and cells safely through vessel walls into deep tissues without major surgery.

R
Rafael Medical Technologies

Rafael Medical has developed a novel anchoring system for safely implanting and retrieving a wide range of intra-vascular devices in a minimally invasive manner. Based on the technology, diagnostic and therapeutic devices can be delivered into small and large blood vessels alike by way of a small-sized delivery system. Following the completion of the SafeFlo Filter the company is now developing additional devices geared to the interventional cardiology market.

L
LifePoint

Lifepoint is a medical technology company developing rapid and cost effective, non-invasive, on-site diagnostic products. The Company has developed and will continue to develop patented, proprietary technologies utilizing saliva as a test specimen to provide blood equivalent diagnostic results without the need for blood or urine.

T
TrueVision Systems

TrueVision Systems, dba TrueVisions 3D Surgical, provides digital 3D visualization and guidance for microsurgery. The company has developed an intelligent, real-time, 3D surgical visualization and computer-aided guidance platform. TrueVision combines 3D visualization and guidance software applications focused on improving accuracy, efficiency, and outcomes for both surgeons and patients. The company is developing 3D guidance applications for microsurgery to improve surgical efficiencies and patient outcomes. The Refractive Cataract Toolset is a computer-aided software for astigmatic correction and advanced IOL positioning.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.